Ferrer Internacional S.A.
21 clinical trials · Sponsor
◉ Watch Ferrer Internacional S.A.
| Record | Firm | Date |
|---|---|---|
| Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and Effectiveness (NCT06499363) | Ferrer Internacional S.A. | 2025-02-25 |
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) (NCT06355531) | Ferrer Internacional S.A. | 2024-07-23 |
| Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral Sclerosis (NCT05866926) | Ferrer Internacional S.A. | 2023-03-06 |
| Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis (NCT05178810) | Ferrer Internacional S.A. | 2021-10-18 |
| Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO) (NCT04065529) | Ferrer Internacional S.A. | 2019-09-11 |
Track Ferrer Internacional S.A. automatically
Every clearance here is in the API, with alerts when new ones post.